Updates in Targeted Therapies, Management Strategies for Non-Small Cell Lung Cancer
“Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths in the United States. Most patients have advanced metastatic disease at diagnosis. Historically, platinum-based chemotherapy was the first-line therapy based on histologic subtype.”
Patient Describes Lung Cancer Journey as ‘Easy’ Thanks to Providence’s Multidisciplinary Cancer Care Team
“Lung nodule clinic: Game-changing technology, superb physicians and caregivers help lead great-grandmother from diagnosis to recovery in two months.”
Biopsy Method, Needle Size Impacts NGS Success Rates in Lung Cancer
“In patients with non–small-cell lung cancer (NSCLC), next-generation sequencing (NGS) has become an essential aspect of identifying the appropriate therapy, and successful NGS relies on sufficient DNA collection. A study published in JTO Clinical Research Reports found varied success rates between biopsy methods and needle sizes.”
UB, partners developing new lung cancer screening test
“Lung cancer is the second most common cancer in both men and women in the United States. It is also the leading cause of cancer death in the nation. To detect lung cancer sooner and improve treatment, a UB-led research team is developing a new, low-cost blood test that aims to make screening more widely available.”
Nonsmoking Women and Lung Cancer: What to Know
“March 20, 2023 — One in 17 women will be diagnosed with lung cancer in their lifetime. Cigarettes are a known risk factor for lung cancer, and many women may abstain from making smoking a habit for this reason. Yet a recent Spanish study reported that female never-smokers are two-thirds more likely to develop the disease than men who have never smoked.”
Improving the Post-Treatment Experience of Cancer Survivors
“Oncology care does not end when a patient’s treatment ends, according to Randall Oyer, MD. Patients who survive cancer experience treatment-related adverse reactions that can follow them for years after treatment. Addressing the needs of these patients requires multidisciplinary and multi-sector action.”
Immunotherapy and Targeted Therapies Continue to Improve Patient Outcomes in Lung Cancer
“Updated data from key trials in non–small cell lung cancer continue to demonstrate the superiority of immunotherapy and targeted therapy regimens for non–small cell lung cancer treatment, but the optimal use of these agents in the adjuvant vs neoadjuvant settings is still contested.”
Research Spotlight: Systemic Immune Modulation by Stereotactic Radiotherapy in Early-Stage Lung Cancer
“Dan G. Duda, DMD, PhD, a researcher and the Director of Translational Research in GI Radiation Oncology at the Edwin L. Steele Laboratories at Massachusetts General Hospital, is the senior author of an article in the journal NPJ Precision Oncology, “Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer.”
Higher Cancer Rates Found in Military Pilots, Ground Crews
“A Pentagon study has found high rates of cancer among military pilots and, for the first time, shows that ground crews who fuel, maintain and launch those aircraft are also getting sick.”
New study supports saving more lung tissue in lung cancer surgeries
“The traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous tissue by removing an entire lung lobe.”
Lung Cancer Screening and Early Detection Drastically Improves Survival Rates
“Increases in early-stage lung cancer diagnoses with low-dose computed tomography (CT) screening have led to sustained improvements in survival rates more than 20 years later, researchers said while presenting their study findings at the 2022 Radiological Society of North America annual meeting.”
Video/Podcast:
An Effective and Easy-to-Use Algorithm for Treating Small Cell Lung Cancer
“In this podcast episode, The Oncology Brothers are joined by Dr. Estelamari Rodriguez, University of Miami Health System, to discuss her approach for treating small cell lung cancer (SCLC).”
Expert Perspectives on Molecular Testing in Non–Small Cell Lung Cancer
“Comprehensive discussion on molecular testing strategies utilized in non–small cell lung cancer to help inform treatment decisions.”
Video: How robotic bronchoscopy helps diagnose lung cancer
“When caught early, lung cancer can often be successfully treated. The problem, however, is that there typically aren’t any symptoms in its early stages. That makes the early detection of lung cancer all the more important.”
Lung cancer advocate heads to D.C. to improve research funding
“CLEVELAND, Ohio (WOIO) – When more than 40 lung cancer advocates descend upon the nation’s capitol on March 29, Cleveland’s Portia Booker will be standing with them. She’ll be meeting with members of Congress to improve the amount of federal funding going towards lung cancer research, prevention and screening.”
